CN
CN

News

2026-06-17
Han Kun welcomes Mr. Quan Hou in joining the firm
2026-06-10
Han Kun Advises Everest Medicines in Acquiring an Exclusive License with Vcare PharmaTech for Sumecigrel, a P2Y12 receptor antagonist, in Asia-Pacific Markets
2026-06-10
Han Kun again recognized in MIP's IP STARS rankings
2026-06-05
Han Kun Hong Kong advised the sole sponsor on the listing of LongBio Pharma (Suzhou) Co., Ltd. on the Main Board of the Hong Kong Stock Exchange
2026-06-03
Benchmark Litigation honors multiple Han Kun lawyers and practice areas in its China Regional Rankings 2026
2026-06-02
Han Kun partner Charles Li and Yin Ge honored "Forbes China Legal Pioneer" and "Forbes China Mulan Award", respectively, at the 2025 Forbes China Legal Industry Awards
2026-05-31
Han Kun Partner Alan Huang Speaks at the GCπ × CIETAC Zhejiang Sub-Commission Event
2026-05-30
Aaron Gu of Han Kun Law Offices Invited to Attend BioStock "Global Forum 2026" in Sweden and Deliver a Keynote Speech on Life Sciences
2026-05-29
Han Kun Hong Kong advises Joint Lead Managers on Yiwu State-owned Capital Operation Co., Ltd.'s U.S.$350 million, 3-year bond issuance
2026-05-28
Han Kun garners the "Golden League" and 15 practice and sector awards at the China Business Law Awards 2026
2026-05-28
Han Kun Hong Kong acts as international legal counsel to Ganzhou Tourism Investment Group Co., Ltd. in its issuance of RMB 460 million in three-year sustainable offshore bonds
2026-05-27
Han Kun provides legal services for Viewtrix Technology's Main Board listing in Hong Kong
Year
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 140
  • 141
  • »
  • Han Kun
    Send regular emails covering market and industry trends.
    Subscribe